Simplify Logo

Full-Time

Commercial Counsel

Posted on 3/15/2024

Twist Bioscience

Twist Bioscience

1,001-5,000 employees

Synthetic DNA production and sequencing services

Hardware
Biotechnology
Healthcare

Compensation Overview

$166k - $220kAnnually

+ Bonus + Equity

Mid

Remote in USA

Category
Legal
Legal & Compliance
Required Skills
Communications
Requirements
  • Registered to practice in the United States or be eligible for Registered In-House Counsel (RIHC) status in the United States
  • 3-6 years of relevant experience at a major law firm and/or in-house legal department at a biotech or pharma company
  • Experience drafting, negotiating and managing a high volume of commercial and pharma agreements
  • Familiarity with synthetic biology and sequencing products and processes, drug development landscape, antibody therapies, and personalized medicine
  • Ability to manage outside counsel and assess when consultation with outside counsel is appropriate
  • Strong interpersonal communication and collaboration skills
  • Ability to prioritize and manage multiple tight deadlines in a fast-paced business environment
  • Excellent judgment in assessing risks and benefits
  • Creative problem solver
  • Hands-on attorney
  • Experience building for scale
  • Experience with domestic (U.S.) and international contracts
Responsibilities
  • Draft, review and negotiate a variety of commercial, biopharma, and other legal documents
  • Develop standard terms and template language for commercial and biopharma agreements
  • Draft and maintain applicable playbooks
  • Manage processes and workflows governing the intake, review, and approval of commercial and biopharma agreement requests
  • Advise business and cross functional stakeholders on best practices and legal updates affecting contracting
  • Other responsibilities as assigned

Twist Bioscience specializes in synthetic DNA production, offering genes, libraries, NGS target enrichment, oligo pools, and antibody services, powered by a proprietary silicon-based manufacturing process. Their technology enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing, catering to diverse fields such as medicine, agriculture, industrial chemicals, and data storage.

Company Stage

IPO

Total Funding

$585.6M

Headquarters

San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

7%
INACTIVE